Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Clinical Neurology,Neurology,Oncology
Reference54 articles.
1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, Groups EOfRaToCBTaR, Group NCIoCCT (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996. doi: 10.1056/NEJMoa043330
2. Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T (2009) Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 27:4733–4740. doi: 10.1200/JCO.2008.19.8721
3. Institute NC (2015) National Cancer Institute Annual Plan and Budget Proposal—Fiscal Year 2016. National Cancer Institute. http://www.cancer.gov/about-nci/budget/annual-plan/nci-plan-2016.pdf . Accessed 1 Dec 2015
4. Ottenhausen M, Bodhinayake I, Banu M, Kesavabhotla K, Ray A, Boockvar JA (2013) Industry progress report on neuro-oncology: Biotech update 2013. J Neurooncol 115:311–316. doi: 10.1007/s11060-013-1222-3
5. Haber JS, Banu MA, Ray A, Kesavabhotla K, Boockvar JA (2013) Industry progress report on neuro-oncology: a biotech update. J Neurooncol 112:315–321. doi: 10.1007/s11060-012-1036-8
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献